Cargando…
Development of Novel Small-Molecule Activators of Pyruvate Kinase Muscle Isozyme 2, PKM2, to Reduce Photoreceptor Apoptosis
Treatment options are lacking to prevent photoreceptor death and subsequent vision loss. Previously, we demonstrated that reprogramming metabolism via the pharmacologic activation of PKM2 is a novel photoreceptor neuroprotective strategy. However, the features of the tool compound used in those stud...
Autores principales: | Wubben, Thomas J., Chaudhury, Sraboni, Watch, Brennan T., Stuckey, Jeanne A., Weh, Eric, Fernando, Roshini, Goswami, Moloy, Pawar, Mercy, Rech, Jason C., Besirli, Cagri G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222839/ https://www.ncbi.nlm.nih.gov/pubmed/37242488 http://dx.doi.org/10.3390/ph16050705 |
Ejemplares similares
-
Metabolic Alterations Caused by Simultaneous Loss of HK2 and PKM2 Leads to Photoreceptor Dysfunction and Degeneration
por: Weh, Eric, et al.
Publicado: (2023) -
Small molecule activation of metabolic enzyme pyruvate kinase muscle isozyme 2, PKM2, circumvents photoreceptor apoptosis
por: Wubben, Thomas J., et al.
Publicado: (2020) -
Hexokinase 2 is dispensable for photoreceptor development but is required for survival during aging and outer retinal stress
por: Weh, Eric, et al.
Publicado: (2020) -
Photoreceptor metabolic reprogramming provides survival advantage in acute stress while causing chronic degeneration
por: Wubben, Thomas J., et al.
Publicado: (2017) -
Photoreceptor metabolic reprogramming: current understanding and therapeutic implications
por: Pan, Warren W., et al.
Publicado: (2021)